Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Arcturus Therapeutics Holdings Inc (NQ: ARCT )

26.60 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 26.60
Bid (Size) 25.00 (1)
Ask (Size) 26.96 (2)
Prev. Close 26.60
Today's Range 26.60 - 26.60
52wk Range 11.70 - 33.80
Shares Outstanding 26,562,951
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Gilead Sciences Stock Reaches 80-Plus Relative Strength Rating Benchmark
On Thursday, Gilead Sciences stock had its Relative Strength (RS) Rating upgraded to 81, up from 78 a day earlier. 
Via Investor's Business Daily
Ionis Pharmaceuticals Stock Sees IBD RS Rating Climb To 79
The Relative Strength Rating for Ionis Pharmaceuticals stock moved into a new percentile Wednesday, as it got a lift from 65 to 79. 
Via Investor's Business Daily

Performance

YTD
+59.28%
+59.28%
1 Month
+1.84%
+1.84%
3 Month
+63.69%
+63.69%
6 Month
+54.02%
+54.02%
1 Year
+33.80%
+33.80%

More News

Read More
Amicus Therapeutics Stock Scores Relative Strength Rating Upgrade; Hits Key Benchmark
Via Investor's Business Daily
Ultragenyx Pharm Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
Via Investor's Business Daily
Analyst's Vote of Confidence: Arcturus' COVID-19 Vaccine Efforts Set to Pay Off in Japan and Beyond
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023
Via Benzinga
Unity Software, Tapestry, CIRCOR International And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Arcturus Therapeutics: Q1 Earnings Insights
Via Benzinga
Arcturus Therapeutics Announces First Quarter 2023 Financial Update and Pipeline Progress
From Arcturus Therapeutics Holdings Inc.
Via Business Wire
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 9, 2023
From Arcturus Therapeutics Holdings Inc.
Via Business Wire
Why Arcturus Therapeutics Stock Is Soaring Today
Via The Motley Fool
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Sprinklr, EVgo, Emergent BioSolutions And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Arcturus Therapeutics's Return On Capital Employed Insights
Via Benzinga
RH, Semtech And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
S&P 500 Up 1%; Bluebird Bio Shares Plummet
Via Benzinga
Stocks Rise As Investors Bet On Bank Recovery
Via Talk Markets
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Arcturus Therapeutics Ltd. (NASDAQ: ARCT) Leading the Way in Wednesday Trading Based on Percentage Gain
Via Investor Brand Network
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Nasdaq Rises 1%; US Pending Home Sales Increase In February
Via Benzinga
Arcturus Therapeutics Stock Is Rising Wednesday: What's Going On?
Via Benzinga
US Stocks Open Higher, Dow Jumps Over 200 Points
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Shift Technologies Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.